Lista de obras -

"The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis".

artículo científico publicado en 2015

2019 ARIA Care pathways for allergen immunotherapy

artículo científico publicado en 2019

A call to arms of specialty societies to review the WHO International Classification of Diseases, Eleventh Revision terms appropriate for the diseases they manage: The example of the Joint Allergy Academies

artículo científico publicado en 2017

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis

artículo científico publicado en 2014

ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

artículo científico publicado en 2020

Adjuvants for immunotherapy

artículo científico

Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles

artículo científico publicado en 2017

Allergen Immunotherapy Outcomes and Unmet Needs: A Critical Review.

artículo científico publicado en 2016

Allergen Immunotherapy for Atopic Dermatitis: Is There Room for Debate?

artículo científico publicado en 2016

Allergen immunotherapy for allergic asthma: protocol for a systematic review

artículo científico publicado en 2015

Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews.

artículo científico

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review.

artículo científico publicado en 2016

Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma

artículo científico publicado en 2013

Allergen immunotherapy for insect venom allergy: protocol for a systematic review

artículo científico publicado en 2015

Allergen immunotherapy: clinical outcomes assessment

artículo científico

Allergen injection immunotherapy for perennial allergic rhinitis

artículo científico publicado en 2008

Allergen injection immunotherapy for perennial allergic rhinitis

scholarly article by Moises A Calderon et al published 8 January 2019 in Cochrane Database of Systematic Reviews

Allergen injection immunotherapy for seasonal allergic rhinitis

artículo científico publicado en 2007

Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy

scientific article published on 01 January 2011

An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.

artículo científico

An evidence-based appraisal of the surrogate markers of efficacy of allergen immunotherapy ⬇️

artículo científico publicado el 1 de agosto de 2011

Anaphylaxis: still a ghost behind allergen immunotherapy

artículo científico

Are meta-analysis-based comparisons solid evidence?

scientific article published on 20 June 2013

Assessment of disease control in allergic rhinitis

artículo científico publicado en 2013

Basophil expression of diamine oxidase: a novel biomarker of allergen immunotherapy response

artículo científico publicado en 2014

Beta-2 agonists for exercise induced asthma

artículo científico publicado en 2009

Beta₂-agonists for exercise-induced asthma

artículo científico publicado en 2013

Categorization of allergic disorders in the new World Health Organization International Classification of Diseases

artículo científico publicado en 2014

Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose

artículo científico publicado en 2015

Cochrane Review: Sublingual immunotherapy for treating allergic conjunctivitis

article

Collaboration between specialties for respiratory allergies in the International Classification of Diseases (ICD)-11.

artículo científico publicado en 2017

Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials ⬇️

artículo científico publicado el 1 de junio de 2012

Critical view of anaphylaxis epidemiology: open questions and new perspectives.

artículo científico publicado en 2018

Dissemination of definitions and concepts of allergic and hypersensitivity conditions

artículo científico publicado en 2016

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy

artículo científico publicado en 2012

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial

artículo científico

Efficacy of allergen-specific immunotherapy for patients with atopic dermatitis.

artículo científico publicado en 2013

Erratum to: Allergen immunotherapy for allergic asthma: protocol for a systematic review

artículo científico publicado en 2017

Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review.

artículo científico publicado en 2017

Erratum to: Allergen immunotherapy for insect venom allergy: protocol for a systematic review

artículo científico publicado en 2017

Evidence of adherence to allergen-specific immunotherapy

artículo científico publicado en 2009

Fatal anaphylaxis registries data support changes in the who anaphylaxis mortality coding rules

artículo científico publicado en 2017

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity

artículo científico publicado en 2008

Implementation gaps for asthma prevention and control

artículo científico publicado en 2017

International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics

artículo científico publicado en 2016

International consensus on allergy immunotherapy.

artículo científico

MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

artículo científico publicado en 2016

Making allergic and hypersensitivity conditions visible in the International Classification of Diseases-11

artículo científico publicado en 2015

Mapping hypersensitivity/allergic diseases in the International Classification of Diseases (ICD)-11: cross-linking terms and unmet needs.

artículo científico publicado en 2015

Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy-An NIAID/AHRQ Workshop

scientific article published on 05 February 2019

Monoallergen sublingual immunotherapy versus multiallergen subcutaneous immunotherapy for allergic respiratory diseases: a debate during the AAAAI 2013 Annual Meeting in San Antonio, Texas

artículo científico

Nasal allergen-neutralizing IgG4 antibodies block IgE-mediated responses: Novel biomarker of subcutaneous grass pollen immunotherapy

scientific article published on 14 November 2018

Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy

artículo científico publicado en 2014

New Allergic and Hypersensitivity Conditions Section in the International Classification of Diseases-11.

artículo científico publicado en 2016

Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

artículo científico publicado en 2019

Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes.

artículo científico publicado en 2012

Perspectives on the International Classification of Diseases, 11th Revision, developments in allergy clinical practice in the United States

artículo científico publicado en 2016

Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol.

artículo científico publicado en 2015

Reaching multidisciplinary consensus on classification of anaphylaxis for the eleventh revision of the World Health Organization's (WHO) International Classification of Diseases (ICD-11)

artículo científico publicado en 2017

Real-life clinical practice and management of polysensitized patients with respiratory allergies: a large, global survey of clinicians prescribing allergen immunotherapy.

artículo científico publicado en 2016

Recombinant allergen immunotherapy: clinical evidence of efficacy--a review

artículo científico

Research needs in allergy: an EAACI position paper, in collaboration with EFA.

artículo científico publicado en 2012

Revisiting Desensitization and Allergen Immunotherapy Concepts for the International Classification of Diseases (ICD)-11.

artículo científico publicado en 2016

Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018

scientific article published on 31 May 2019

Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial

artículo científico publicado en 2015

Smoothing the transition from International Classification of Diseases, Tenth Revision, Clinical Modification to International Classification of Diseases, Eleventh Revision.

artículo científico publicado en 2016

Specific allergen immunotherapy for the treatment of atopic eczema

artículo científico publicado en 2016

Specific allergen immunotherapy for the treatment of atopic eczema

artículo científico publicado en 2010

Specific immunotherapy for latex allergy

artículo científico publicado en 2011

Specific immunotherapy for latex allergy

Subcutaneous Immunotherapy and Sublingual Immunotherapy: Comparative Efficacy, Current and Potential Indications, and Warnings--United States Versus Europe

artículo científico publicado en 2016

Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe

artículo científico publicado el 27 de octubre de 2010

Sublingual allergen immunotherapy for respiratory allergies: what is new?

artículo científico publicado en 2014

Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus report

artículo científico

Sublingual immunotherapy for allergic rhinitis

artículo científico publicado en 2010

Sublingual immunotherapy for treating allergic conjunctivitis

artículo científico publicado en 2011

Sublingual immunotherapy for treating allergic conjunctivitis

artículo científico publicado en 2009

Supporting the validation of the new allergic and hypersensitivity conditions section of the World Health Organization International Classification of Diseases-11.

artículo científico publicado en 2016

The Potential Role of Allergen Immunotherapy in Stepping Down Asthma Treatment.

artículo científico publicado en 2016

The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease

artículo científico publicado en 2017

The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient survey

artículo científico publicado en 2015

Topical nasal corticosteroids versus oral antihistamines for allergic rhinitis

artículo científico publicado en 2010

Topical nasal corticosteroids versus oral antihistamines for allergic rhinitis

artículo científico publicado en 2017

Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report

artículo científico

Updating Allergy and/or Hypersensitivity Diagnostic Procedures in the WHO ICD-11 Revision

artículo científico publicado en 2016

Lista de obras de

"The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis".

2019 ARIA Care pathways for allergen immunotherapy

A call to arms of specialty societies to review the WHO International Classification of Diseases, Eleventh Revision terms appropriate for the diseases they manage: The example of the Joint Allergy Academies

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis

ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

Adjuvants for immunotherapy

Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles

Allergen Immunotherapy Outcomes and Unmet Needs: A Critical Review.

Allergen Immunotherapy for Atopic Dermatitis: Is There Room for Debate?

Allergen immunotherapy for allergic asthma: protocol for a systematic review

Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews.

Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review.

Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma

Allergen immunotherapy for insect venom allergy: protocol for a systematic review

Allergen immunotherapy: clinical outcomes assessment

Allergen injection immunotherapy for perennial allergic rhinitis

Allergen injection immunotherapy for perennial allergic rhinitis

Allergen injection immunotherapy for seasonal allergic rhinitis

Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy

An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.

An evidence-based appraisal of the surrogate markers of efficacy of allergen immunotherapy ⬇️

Anaphylaxis: still a ghost behind allergen immunotherapy

Are meta-analysis-based comparisons solid evidence?

Assessment of disease control in allergic rhinitis

Basophil expression of diamine oxidase: a novel biomarker of allergen immunotherapy response

Beta-2 agonists for exercise induced asthma

Beta₂-agonists for exercise-induced asthma

Categorization of allergic disorders in the new World Health Organization International Classification of Diseases

Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose

Cochrane Review: Sublingual immunotherapy for treating allergic conjunctivitis

Collaboration between specialties for respiratory allergies in the International Classification of Diseases (ICD)-11.

Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials ⬇️

Critical view of anaphylaxis epidemiology: open questions and new perspectives.

Dissemination of definitions and concepts of allergic and hypersensitivity conditions

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial

Efficacy of allergen-specific immunotherapy for patients with atopic dermatitis.

Erratum to: Allergen immunotherapy for allergic asthma: protocol for a systematic review

Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review.

Erratum to: Allergen immunotherapy for insect venom allergy: protocol for a systematic review

Evidence of adherence to allergen-specific immunotherapy

Fatal anaphylaxis registries data support changes in the who anaphylaxis mortality coding rules

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity

Implementation gaps for asthma prevention and control

International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics

International consensus on allergy immunotherapy.

MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

Making allergic and hypersensitivity conditions visible in the International Classification of Diseases-11

Mapping hypersensitivity/allergic diseases in the International Classification of Diseases (ICD)-11: cross-linking terms and unmet needs.

Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy-An NIAID/AHRQ Workshop

Monoallergen sublingual immunotherapy versus multiallergen subcutaneous immunotherapy for allergic respiratory diseases: a debate during the AAAAI 2013 Annual Meeting in San Antonio, Texas

Nasal allergen-neutralizing IgG4 antibodies block IgE-mediated responses: Novel biomarker of subcutaneous grass pollen immunotherapy

Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy

New Allergic and Hypersensitivity Conditions Section in the International Classification of Diseases-11.

Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes.

Perspectives on the International Classification of Diseases, 11th Revision, developments in allergy clinical practice in the United States

Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol.

Reaching multidisciplinary consensus on classification of anaphylaxis for the eleventh revision of the World Health Organization's (WHO) International Classification of Diseases (ICD-11)

Real-life clinical practice and management of polysensitized patients with respiratory allergies: a large, global survey of clinicians prescribing allergen immunotherapy.

Recombinant allergen immunotherapy: clinical evidence of efficacy--a review

Research needs in allergy: an EAACI position paper, in collaboration with EFA.

Revisiting Desensitization and Allergen Immunotherapy Concepts for the International Classification of Diseases (ICD)-11.

Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018

Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial

Smoothing the transition from International Classification of Diseases, Tenth Revision, Clinical Modification to International Classification of Diseases, Eleventh Revision.

Specific allergen immunotherapy for the treatment of atopic eczema

Specific allergen immunotherapy for the treatment of atopic eczema

Specific immunotherapy for latex allergy

Specific immunotherapy for latex allergy

Subcutaneous Immunotherapy and Sublingual Immunotherapy: Comparative Efficacy, Current and Potential Indications, and Warnings--United States Versus Europe

Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe

Sublingual allergen immunotherapy for respiratory allergies: what is new?

Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus report

Sublingual immunotherapy for allergic rhinitis

Sublingual immunotherapy for treating allergic conjunctivitis

Sublingual immunotherapy for treating allergic conjunctivitis

Supporting the validation of the new allergic and hypersensitivity conditions section of the World Health Organization International Classification of Diseases-11.

The Potential Role of Allergen Immunotherapy in Stepping Down Asthma Treatment.